Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a carrier. And we cite every word.
People reach for Baobab for more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
8
uses studied
12
papers cited
0
hidden from you
What the published studies found
Early evidence · 2 studies
Aging/Wrinkles
Two industry-funded in vitro/ex vivo studies suggest Adansonia digitata (baobab) extracts may support collagen production, fibroblast proliferation, and reduce cellular senescence markers via microRNA modulation (miR-146a, miR-19b). However, no human clinical trials or RCTs exist, so anti-wrinkle efficacy in people remains unproven.
Evidence for baobab (Adansonia digitata) against fungal infection is limited to in-vitro work: a 1995 ethnopharmacology screen found baobab extract showed antifungal activity only 'to a lesser extent' compared to other plants, and a 2024 study demonstrated antifungal effects of silver/iron nanoparticles synthesized using baobab shell extract against tomato plant pathogens (activity attributable to the nanoparticles, not baobab itself). No human clinical trials, RCTs, or studies against human-pathogenic fungi with the oil itself were identified.
Only preclinical and secondary evidence exists: one mouse study (PMID 29084687) showed Adansonia digitata leaf extract had dose-dependent antinociceptive/analgesic effects in writhing, tail-flick, and hot-plate pain models, and a 2023 narrative review (PMID 37432337) mentions analgesic and anti-inflammatory activity among baobab's properties. No human clinical trials, RCTs, or studies on baobab oil specifically for muscle pain were found.
Evidence for baobab in dermatitis is minimal: a 2026 in vitro study showed baobab fruit ethanol extracts (not seed oil) reduced inflammatory mediators (IL-6, IL-8, MCP-1) in TNF-α/IFN-γ-stimulated keratinocytes relevant to atopic dermatitis, and a single 1965 Indian journal report claimed benefit of Adansonia digitata in allergic skin disorders. No randomized controlled trials exist, and no study specifically addresses contact dermatitis or topical baobab oil in humans.
The only relevant retrievable study is a 2022 narrative review of African oils in dermatology (PMID 33928725), which documents traditional Baobab oil use for skin care via healer interviews and notes that plant oils generally possess wound-healing, anti-inflammatory, and antimicrobial constituents. However, it cites no clinical trials, controlled studies, or even Baobab-specific preclinical wound-healing data—claims are extrapolated from research on other oils (e.g., coconut oil in rats).
A single Nigerian ethnobotanical survey (PMID 17919209) lists Adansonia digitata (baobab) among plants traditionally used by herbal prescribers for skin conditions, with eczema (including atopic and infantile eczema) among conditions for which unspecified herbal mixtures were reportedly applied. However, the study provides no controlled testing, no baobab-specific efficacy data, and no clinical trials for baobab oil in eczema.
The only identified study is a 2007 ethnobotanical survey of Nigerian dermatology patients that lists Adansonia digitata (baobab) among traditionally used plants, but it provides no clinical efficacy data for hair loss and explicitly reports that herbal remedies did not improve alopecia. There are no RCTs, controlled trials, or in-vitro studies supporting baobab oil for hair loss or thinning.
A 2025 narrative review (PMID 40103463) identified baobab (Adansonia digitata) oil among 21 vegetable oils with skin-whitening/depigmenting activity, but the underlying evidence is entirely in vitro, with activity attributed to fatty acid composition. The review explicitly states that clinical trials are lacking and should be encouraged, meaning there is currently no human clinical evidence supporting baobab oil for hyperpigmentation.
